Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: Putting guidelines into practice

European Journal of Heart Failure

Volumn 3, Issue 4, 2001, Pages 495-502

  John, McMurray ^a   Alain, Cohen Solal ^b   Rainer, Dietz ^c   Eric, Eichhorn ^d   Leif, Erhardt ^e   Richard, Hobbs ^f   Aldo, Maggioni ^g   Ileana, Pina ^h   Jordi, Soler Soler ⁱ   Karl, Swedberg ^j  

^a Clin Res Initiative Heart Failure   (United Kingdom)

^b BEAUJON HOSPITAL   (France)

^c Franz Volhard Klinik   (Germany)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f Department of Primary Care and General Practice ^*  (United Kingdom)

^g ANMCO RESEARCH CENTER   (Italy)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^j SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Angiotensin converting enzyme inhibitors; Beta blockers; Clinical recommendations; Heart failure; Spironolactone

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ARTICLE; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT PLANNING;

EID: 0034882356     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00173-8     Document Type: Article

References (35)

1. Effect of enalapril on mortality in severe congestive heart failure
2. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
3. Prevalence, aetiology and management of heart failure in general practice
4. Why are angiotensin converting enzyme inhibitors under-utilised in the treatment of heart failure by general practitioners?
5. Patterns of angiotensin-converting enzyme inhibitors use in congestive heart failure in two community hospitals
6. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995
7. Treatment of patients admitted to the hospital with congestive heart failure: Speciality-related disparities in practice patterns and outcomes
8. European survey of primary care physician perceptions and practice in heart failure diagnosis and management (Euro-HF-study)
9. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
10. Economics of chronic heart failure
11. The effect of sprionolactone on morbidity and mortality in patients with severe heart failure
12. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
13. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
14. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
15. Effects of controlled-release metoprolol on total mortality, hospitalisations, and well-being in patients with heart failure (MERIT-HF)
16. Effects of carvedilol on survival in severe chronic heart failure
17. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction
18. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
19. Health and economic benefits of increased beta-blocker use following myocardial infarction
20. Diagnosis and management of heart failure
21. Guidelines for the evaluation and management of heart failure
22. Guidelines for the diagnosis of heart failure Task force on heart failure of the European Society of Cardiology
23. Concise guide to the management of heart failure
24. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure
25. Medical treatment of heart failure: The Canadian Cardiovascular Society's consensus conference revisited
26. Guidelines for management of patients with chronic heart failure in Australia
27. North of England evidence based development project: Guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure
28. Consensus recommendations for the management of chronic heart failure
29. Heart Failure Society of America Practice Guidelines: HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction: Pharmacological approaches. Guideline committee members and the executive council for the heart failure society of America
30. The effect of digoxin on mortality and morbidity in patients with heart failure
31. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
32. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
33. Carvedilol alone or in combination with digoxin for the management of atrial fibrilation in patients with heart failure?